Status Approved
First Submitted Date
2020/05/25
Registered Date
2020/05/29
Last Updated Date
2020/12/01
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0005069 |
---|---|
Unique Protocol ID | NCC2019-0256 |
Public/Brief Title | A study to analysis the usefulness of personalized 3D thyroid model |
Scientific Title | A prospective study to assess the usefulness of 3-dimensional thyroid model on the informed consent and understanding of patients prior to thyroid surgery |
Acronym | THY3D |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | NCC2019-0256 |
Approval Date | 2019-11-04 |
Institutional Review Board Name | National Cancer Center Institutional Review Board |
Institutional Review Board Address | 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do |
Institutional Review Board Telephone | 031-920-0425 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Yuh-Seog Jung |
Title | Senior Researcher |
Telephone | +82-31-920-1685 |
Affiliation | National Cancer Center |
Address | 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do |
Contact Person for Public Queries | |
Name | Jungirl Seok |
Title | Clinical Staff |
Telephone | +82-31-920-1625 |
Affiliation | National Cancer Center |
Address | 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do |
Contact Person for Updating Information | |
Name | Jungirl Seok |
Title | Clinical Staff |
Telephone | +82-31-920-1625 |
Affiliation | National Cancer Center |
Address | 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Completed | |
Date of First Enrollment | 2020-07-07 Actual | |
Target Number of Participant | 60 | |
Primary Completion Date | 2020-12-01 , Actual | |
Study Completion Date | 2020-12-01 , Actual | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | National Cancer Center | |
Recruitment Status | Completed | |
Date of First Enrollment | 2020-07-07 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | National Cancer Center |
Organization Type | Medical Institute |
Project ID | 1810866-2 |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | National Cancer Center |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Background: multimedia-based resources were introduced to help patients in understanding their disease. Recently, the use of 3D-printing in medicine has been increased, it enabled us to explain to a patient using a personalized 3D model. Purpose: To prospectively evaluate the usefulness of 3D models of the thyroid gland for improving patient understanding of thyroid surgery and disease. Subjects included: Patients diagnosed with thyroid cancer or disease who are scheduled for surgery at our institution and who have agreed to a study of thyroid 3D model construction. Intervention: Group A randomized by the Block Randomization method uses a 3D model to describe the surgical consent, and Group B receives a description of the operation using only documentation in a conventional manner. A total of two surveys will be given each at the time of receiving a surgical consent (second outpatient visit) and at the date of admission for surgery. Outcome Measures: Measure questionnaires evaluated at two different time points: (1) general information about the operation, (2) the need for the operation, (3) the risk of the operation, and (4) satisfaction with the explanation. Research hypothesis: There will be an improvement in the understanding of disease, the necessity of risk, the understanding of risk, and overall explanation satisfaction in the group of patients who described surgery through 3D model. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Others (Tool used to explain to patient) |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Single |
Blinded Subject | Subject |
Allocation | RCT |
Intervention Type | Others |
Intervention Description | Group A randomly assigned by the Block Randomization method uses a 3D model when explaining a surgical consent form, and Group B receives a description of the surgery using only a document in a conventional manner. |
Number of Arms | 2 |
Arm 1 |
Arm Label Arm B |
Target Number of Participant 30 |
|
Arm Type No intervention |
|
Arm Description The second visit after the study consent (first visit) is approved by using the document only in the conventional manner. |
|
Arm 2 |
Arm Label Arm A |
Target Number of Participant 30 |
|
Arm Type Experimental |
|
Arm Description On the second visit after the study consent (first visit), a surgical consent is obtained using the 3D model. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (C00-D48)Neoplasms (C73)Malignant neoplasm of thyroid gland Cancer of Thyroid Thyroid neoplasms |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 20Year~70Year |
|
Description Patients who have been diagnosed with thyroid cancer or disease and are planning to undergo surgery at the research institute, and have consented to the study of thyroid 3D model construction. |
|
Exclusion Criteria |
Withdrawal of consent at patient's request |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Not applicable | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Degree of understanding of the risk of surgery |
|
Timepoint | Immediately after receiving a written consent and at the time of admission for surgery |
|
Primary Outcome(s) 2 | ||
Outcome | Satisfaction with explaining surgery |
|
Timepoint | Immediately after receiving a written consent and at the time of admission for surgery |
|
Primary Outcome(s) 3 | ||
Outcome | Degree of understanding of the disease |
|
Timepoint | Immediately after receiving a written consent and at the time of admission for surgery |
|
Primary Outcome(s) 4 | ||
Outcome | Degree of understanding of the necessity of surgery |
|
Timepoint | Immediately after receiving a written consent and at the time of admission for surgery |
|
Secondary Outcome(s) 1 | ||
Outcome | Changes in survey scores (primary outcomes) at intervals between two questionnaires |
|
Timepoint | At the end of the second questionnaire |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동